To evaluate the effects of tumor cell–derived IL-6 in PDAC cachexia, we used CRISPR/Cas9 to edit the Il6 gene in a cell line isolated from the KPC (genetically engineered mouse model, KrasG12D;Trp53R172H:Pdx1-Cre). This evidence concerns the gene IL6 and neoplasm.